期刊文献+

以双侧肾上腺及腹膜后嗜铬细胞瘤为首发表现的2A型多发性内分泌腺瘤病 被引量:3

下载PDF
导出
摘要 目的提高2A型多发性内分泌腺瘤病(MEN2A)的认识及诊治水平。方法对我院收治的1例MEN2A临床资料进行回顾性分析,并结合文献进行讨论。结果本例因间断头晕、头痛1个月入院。治疗过程中血压突然急剧升高,最高达200/110mmHg。经B超、CT及MRI检查发现甲状腺肿块及嗜铬细胞瘤,行手术治疗,术后明确诊断为MEN2A。追问病史,家族中有4人罹患嗜铬细胞瘤及甲状腺髓样癌,均经手术切除及术后病理证实。结论 MEN2A诊断主要依赖相应的内分泌、B超和CT检查,对高危家族进行基因检测并早期行预防性甲状腺全切,可以有效预防本病的发展及提高治愈率。对于已经发生的MEN2A病例,行甲状腺全切加颈部淋巴结清扫及保留肾上腺皮质的肾上腺切除术,是治愈本病的根本方法。
出处 《临床误诊误治》 2010年第8期765-766,共2页 Clinical Misdiagnosis & Mistherapy
  • 相关文献

参考文献6

  • 1Machens A.Early malignant progression of hereditary medullary thyroid cancer[J].N Engl J Med,2004,350(9):943.
  • 2Eng C,Clayton D,Schuffenecker I,et al.The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2.International RET mutation consortium analysis[J].JAMA,1996,276(19):1575-1579.
  • 3Dionigi G,Tanda M L,Piantanida E.Medullary thyroid carcinoma:surgical treatment advances[J].Curr Opin Otolaryngol Head Neck Surg,2008,16(2):158-162.
  • 4Rodriguez JM,Balsalobre M,Ponce JL,et al.Pheochromocytoma in MEN2A syndrome[J].Study of 54 patients.World J Surg,2008,32(11):2520-2526.
  • 5Ng L,Libertino J M.Adrenocortical carcinoma:diagnosis,evaluation and treatment[J].J Urol,2003,169(1):5-11.
  • 6Kloos R T,Eng C,Evans D B,et al.Medullary thyroid cancer:management guidelines of the American Thyroid Association[J].Thyroid,2009,19(6):565-612.

同被引文献40

  • 1张金双,李雪,吴筱辉,王珊珊,黄友梅,李萌,周君,苏冬明.2A型多发性内分泌腺瘤病超声表现[J].中华医学超声杂志(电子版),2013,10(3):231-233. 被引量:5
  • 2石文媛,梁萍,邵秋杰,王旸,任贺.肾上腺髓质脂肪瘤的超声诊断价值[J].中华超声影像学杂志,2007,16(9):777-779. 被引量:3
  • 3Fassnacht M, Kenn W. AIIolio B. Adrenal tumors: how to es- tablish malignancy[J]. J Endocrinol Invest , 2004,27 (4): 387-399.
  • 4Renard J, Clerici T, Licker M, et al. Pheochromocyto- ma and abdominal paraganglioma [- J 1. J Visc Surg, 2011, 148(6): e409-416.
  • 5Neumann H P, Vortmeyer A, Schmidt D, et al. Evi- dence of MEN-2 in the original description of classic pheochromocytomaFJ~. N Engl J Med, 2007, 357. 1311-1315.
  • 6Elder E E, Elder G, Larsson C. Pheochromocytoma and functional paraganglioma syndrome., no longer the 10% tumor[-J~. J Surg Oncol, 2005, 89: 193-201.
  • 7Amar L, Bertherat J, Baudin E, et al. Genetic testing in pheochromocytoma or functional paragangliomal-J-]. J Clin Oncol, 2005, 23:8812-8818.
  • 8Benn D E, Gimenez-Roqueplo A P, Reilly J R, et al. Clinical presentation and penetrance of pheochromocy- toma/paraganglioma syndromesl-J~. J clin Endocrinol Metab, 2006, 91:827-836.
  • 9Timmer H J, Kozupa A, Eisenhofer G, et al. Clinical presentation, biochemical phenotypes, and genotype- phenotype correlations in patients with succinate dehy- drogenase subunit B-associated pheochromocytoma and paragangliomarJ']. J Clin Endocrinol Metab, 2007, 92. 779-786.
  • 10Pacak K, Eisenhofer G, llias I. Diagnosis of pheochro- mocytoma with special emphasis on MEN2 syndrome [J]. Hormones(Athens), 2009, 8.111. 116.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部